Abrilumab

Tax included
Abrilumab is a fully human monoclonal antibody directed against α4β7. Abrilumab selectively binds the α4β7 integrin heterodimer. Abrilumab can be used for the research of inflammatory bowel disease (IBD).
MedChemExpress 
HY-P99184

Data sheet

Size
Multiple sizes
Reactivity
Integrin
Application
COVID-19-immunoregulation
CAS
1342290-43-0